Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NeoGenomics Inc. Common Stock (NEO) vs Unilever plc (UL) Price & Performance

NeoGenomics Inc. Common StockTrade
Unilever plcTrade

Price performance (Past 24H)

Key statistics

NeoGenomics Inc. Common Stock vs Unilever plc — how do they compare? NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.14B), while Unilever plc trades at $65 (market cap $134.00B). The key difference: Unilever plc is far larger — about 62.6× NeoGenomics Inc. Common Stock's market cap, and Unilever plc pays a 3.4% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Unilever plc for 112 Days on average.

NEOUL
Market Cap
$2.14B$134.00B
Volume
2,228,4002,393,833
Sector
HealthConsumer Staples
52-Week High
$19.91$74.59
52-Week Low
$7.19$55.05
Typical Hold Time
0 Days112 Days
Enterprise Value
$2.44B$158.93B
Dividend Yield
—3.4%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NeoGenomics Inc. Common Stock

No Aura AI signal available yet.

Unilever plc

Unilever (UL) trades at $63.86, up 1.45% on the day, with a bullish technical signal and strong profitability metrics including a 18.32% net income margin and 54.56% ROE. Recent earnings have consistently missed expectations, but the company is undergoing strategic portfolio streamlining, including a planned $65 billion food business merger with McCormick, which is under regulatory scrutiny. Cash flow from operations remains robust at $8.35 billion for 2025, though net cash flow was negative $2.08 billion due to significant investing and financing outflows.

The outlook is mixed: analyst consensus is a 'Hold' with a $66.08 price target, suggesting modest upside, but risks include execution of the McCormick deal, competitive pressures, and recent earnings misses. The stock's valuation at a P/E of 21.87 appears reasonable given its defensive emerging market exposure and high margins, but investor sentiment is cautious pending clearer signs of sustained growth.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NEO
100% Buy0% Sell
Avg holding period · 0 Days
UL
85% Buy15% Sell
Avg holding period · 112 Days

About NeoGenomics Inc. Common Stock

NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.

Read more on NEO →

About Unilever plc

Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years

Read more on UL →